Immediately after the president’s action, Health and Human Services Secretary Robert F. Kennedy Jr. said he wanted to return to a time when “many of [the pharmaceutical companies] didn’t advertise.” Food and Drug Administration Commissioner Martin Makary was even clearer on CNBC: The FDA, he said, “will require more disclosure and longer ads that may make the ads no longer feasible.”
Don't let government come between doctors and patients
→
At the Semafor World Economy Summit last week, Food and Drug Administration Commissioner Martin Makary said he has “no plans to take action” to restrict the availability of mifepristone, the pill used in most medical abortions in the U.S.
Letter to the editor: Don't abandon unborn, mothers
→
